FilingReader Intelligence
Pharmaron proposes dividend, plans share repurchase, elects board
March 28, 2025 at 01:16 AM UTC•By FilingReader AI
Pharmaron Beijing Co., Ltd. (SZSE:300759) announced a proposed 2024 profit distribution plan that includes a cash dividend of RMB 2.00 per 10 shares (tax included), totaling RMB 354.19 million. The company's board of directors approved the plan on March 26, 2025, and it is subject to shareholder approval.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement on the increase of registered capital and amendment of the Articles of AssociationMarch 26, 2025 at 01:11 PM UTC
2024 Internal Control Evaluation ReportMarch 26, 2025 at 01:11 PM UTC
2024 Annual ReportMarch 26, 2025 at 01:11 PM UTC
Internal Control Audit ReportMarch 26, 2025 at 01:11 PM UTC
Special review of non-operating capital occupation and other related capital transactions in 2024March 26, 2025 at 01:11 PM UTC
2024 Annual Audit ReportMarch 26, 2025 at 01:11 PM UTC
2024 Annual Report SummaryMarch 26, 2025 at 01:26 PM UTC
2024 Annual Report of the Board of DirectorsMarch 26, 2025 at 01:26 PM UTC
Announcement on using part of idle self-owned funds to purchase financial productsMarch 26, 2025 at 01:26 PM UTC
SZSE:300759•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Pharmaron Beijing publishes news
Free account required • Unsubscribe anytime